Elixia Healthcare Limited 07022514 false 2024-10-01 2025-09-30 2025-09-30 The principal activity of the company is Dispensing chemist in specialised stores. Digita Accounts Production Advanced 6.30.9574.0 true false 07022514 2024-10-01 2025-09-30 07022514 2025-09-30 07022514 core:CapitalRedemptionReserve 2025-09-30 07022514 core:RetainedEarningsAccumulatedLosses 2025-09-30 07022514 core:ShareCapital 2025-09-30 07022514 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 07022514 core:Non-currentFinancialInstruments core:AfterOneYear 2025-09-30 07022514 bus:SmallEntities 2024-10-01 2025-09-30 07022514 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 07022514 bus:FullAccounts 2024-10-01 2025-09-30 07022514 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 07022514 bus:RegisteredOffice 2024-10-01 2025-09-30 07022514 bus:Director4 2024-10-01 2025-09-30 07022514 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 07022514 core:FurnitureFittings 2024-10-01 2025-09-30 07022514 core:LeaseholdImprovements 2024-10-01 2025-09-30 07022514 core:PlantMachinery 2024-10-01 2025-09-30 07022514 countries:EnglandWales 2024-10-01 2025-09-30 07022514 2024-09-30 07022514 2023-10-01 2024-09-30 07022514 2024-09-30 07022514 core:CapitalRedemptionReserve 2024-09-30 07022514 core:RetainedEarningsAccumulatedLosses 2024-09-30 07022514 core:ShareCapital 2024-09-30 07022514 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 07022514 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 07022514 core:PreviouslyStatedAmount 2024-09-30 iso4217:GBP xbrli:pure

Registration number: 07022514

Elixia Healthcare Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 September 2025

 

Elixia Healthcare Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 4

 

Elixia Healthcare Limited

(Registration number: 07022514)
Abridged Balance Sheet as at 30 September 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

33,470

32,774

Current assets

 

Stocks

5

113,238

76,000

Debtors

292,803

377,872

Cash at bank and in hand

 

230,232

199,958

 

636,273

653,830

Creditors: Amounts falling due within one year

6

(512,940)

(418,928)

Net current assets

 

123,333

234,902

Total assets less current liabilities

 

156,803

267,676

Creditors: Amounts falling due after more than one year

7

-

(8,282)

Provisions for liabilities

(8,156)

-

Net assets

 

148,647

259,394

Capital and reserves

 

Called up share capital

6,146

6,146

Capital redemption reserve

3,854

3,854

Profit and loss account

138,647

249,394

Total equity

 

148,647

259,394

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 12 June 2026 and signed on its behalf by:
 

Dr Andrew Fernando

Director

 

Elixia Healthcare Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Hook Surgery
Reading Road
Hook
Hampshire
RG27 9ED

These financial statements were authorised for issue by the Board on 12 June 2026.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Elixia Healthcare Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold improvements

10% RB

Fixtures and fittings

25% RB

Plant and machinery

25% RB

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Defined benefit pension obligation

Typically defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.

The liability recognised in the balance sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the reporting date minus the fair value of plan assets. The defined benefit obligation is measured using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future payments by reference to market yields at the reporting date on high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension liability.

Actuarial gains and losses are charged or credited to other comprehensive income in the period in which they arise.

 

Elixia Healthcare Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2025

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 20 (2024 - 23).

4

Tangible assets

Total
£

Cost or valuation

At 1 October 2024

125,735

Additions

6,801

At 30 September 2025

132,536

Depreciation

At 1 October 2024

92,961

Charge for the year

6,105

At 30 September 2025

99,066

Carrying amount

At 30 September 2025

33,470

At 30 September 2024

32,774

Included within the net book value of land and buildings above is £22,731 (2024 - £25,257) in respect of long leasehold land and buildings.
 

5

Stocks

2025
£

2024
£

Stock

113,238

76,000

6

Creditors: amounts falling due within one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £7,888 (2024 - £8,542).

7

Creditors: amounts falling due after more than one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £Nil (2024 - £8,282).

8

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £13,209 (2024 - £Nil).